NTRP
NextTrip IncNASDAQCONSUMER CYCLICALTRAVEL SERVICES
Key Statistics
Market Cap
$32.32M
P/E Ratio
—
EPS
$-1.82
Beta
1.57
52W High
$5.20
52W Low
$2.04
50-Day MA
$2.66
200-Day MA
$3.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About NextTrip Inc
Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $3.72M |
| Gross Profit (TTM) | 652,490 |
| EBITDA | $-14.80M |
| Operating Margin | -307.20% |
| Return on Equity | -249.80% |
| Return on Assets | -86.40% |
| Revenue/Share (TTM) | $0.42 |
| Book Value | $0.47 |
| Price-to-Book | 5.62 |
| Price-to-Sales (TTM) | 8.70 |
| EV/Revenue | 9.19 |
| EV/EBITDA | -0.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1839.00% |
| Shares Outstanding | $14.49M |
| Float | $7.67M |
| % Insiders | 47.02% |
| % Institutions | 8.29% |
Historical Volatility
HV 10-Day
62.63%
HV 20-Day
56.09%
HV 30-Day
52.08%
HV 60-Day
86.13%
HV Rank
5.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($7.75 target)
2
BuyMore CONSUMER CYCLICAL Stocks
Data last updated: 6/13/2026